For the Inventor, By the Inventor

Enter inventor name

Cary, NC, United States of America

James D Otvos

USPTO Granted Patents = 41 (Patent Applications = 9)

CIPO Patents = 9 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 435(Granted Patents)

Location History:

Shorewood, WI (US) (1990)
Apex, NC (US) (1994 - 2024)
Cary, NC (US) (2016 - 2024)

Company Filing History:

Liposcience, Inc.

North Carolina State University

Liposciences, LLC

Lipscience, Inc.

5. 5 out of 832,891

Other

patents

Years Active: 1990-2024

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

NMR Spectroscopy

Cardiovascular Risk Evaluations

Diabetes Risk Assessments

Lipoprotein Analysis

Metabolic Vulnerability Index

HDL Particle Number

TMAO Quantification

GlycA Biomarker

Colorectal Cancer Prediction

Insulin Resistance Indexes

Clinical Biosample Evaluation

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12130295 - NMR system and methods for multi-parameter metabolic vulnerability index evaluations (2024-10-29),

2. 11990243 - Multiple-marker risk parameters predictive of conversion to diabetes (2024-05-21),

3. 11988679 - Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter (2024-05-21),

4. 11942187 - Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements (2024-03-26),

5. 11782002 - NMR quantification of TMAO (2023-10-10),

6. 11710568 - Multi-parameter diabetes risk evaluations (2023-07-25),

7. 11703501 - CHD risk stratification evaluations for subjects with high levels of large HDL-P (2023-07-18),

8. 11692995 - NMR measurements of NMR biomarker GlycA (2023-07-04),

9. 11467171 - Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy (2022-10-11),

10. 11231429 - Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter (2022-01-25),

11. 11156685 - NMR analyzers for clinical evaluation of biosamples (2021-10-26),

12. 11156621 - Multi-parameter metabolic vulnerability index evaluations (2021-10-26),

13. 11124837 - Methods and systems for predicting colorectal cancer incidence and mortality (2021-09-21),

14. 11037683 - Multiple-marker risk parameters predictive of conversion to diabetes (2021-06-15),

15. 10852293 - NMR measurements of NMR biomarker GlycA (2020-12-01),

Title: The Innovative Journey of James D. Otvos

Introduction: James D. Otvos, a talented inventor based in Cary, NC (US), has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: James D. Otvos holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, James D. Otvos has successfully brought several cutting-edge inventions to life, revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, James D. Otvos has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, demonstrating his commitment to innovation and teamwork.

Conclusion: James D. Otvos continues to inspire with his innovative spirit and dedication to creating solutions that shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…